Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Cancer Research
|
October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
Urology
|
January 18, 2002
Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels
L Höltl, R Peschel, R Knapp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6
Hannes Steiner, Andreas P Berger, S Godoy-Tundidor, et al.
The Prostate
|
June 1, 1996
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, M V Cronauer, et al.
Carbohydrate Polymers
|
December 28, 2020
How cellulose nanofibrils and cellulose microparticles impact paper strength-A visualization approach
Mathias A Hobisch, Simon Zabler, Sylvia M Bardet, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
Z Culig, A Hobisch, M V Cronauer, et al.
The Journal of Pathology
|
July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors
A Hobisch, A Hittmair, G Daxenbichler, et al.
In Vitro Cellular & Developmental Biology. Animal
|
February 18, 1998
A reliable system for the culture of human prostatic cells
M V Cronauer, I E Eder, A Hittmair, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Cancer Research
|
October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
Urology
|
January 18, 2002
Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels
L Höltl, R Peschel, R Knapp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6
Hannes Steiner, Andreas P Berger, S Godoy-Tundidor, et al.
The Prostate
|
June 1, 1996
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, M V Cronauer, et al.
Carbohydrate Polymers
|
December 28, 2020
How cellulose nanofibrils and cellulose microparticles impact paper strength-A visualization approach
Mathias A Hobisch, Simon Zabler, Sylvia M Bardet, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
Z Culig, A Hobisch, M V Cronauer, et al.
The Journal of Pathology
|
July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors
A Hobisch, A Hittmair, G Daxenbichler, et al.
In Vitro Cellular & Developmental Biology. Animal
|
February 18, 1998
A reliable system for the culture of human prostatic cells
M V Cronauer, I E Eder, A Hittmair, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
Page
of 8